Bacoside A
Based on 1 publication(s) in Google Scholar
Bacoside A is an orally active, blood-brain barrier-permeable triterpenoid saponin that modulates the activities of ATPases, AChE, CaMK2A and iNOS. Derived from Bacopa monniera. Bacoside A exerts significant antioxidant, anti-inflammatory and anti-apoptotic effects by maintaining ion balance, scavenging reactive oxygen species, stabilizing cell membranes, and regulating the expression of NF-κB and apoptosis-related proteins. Bacoside A counteracts morphine-induced reductions in Na+/K+-ATPase, Ca2+-ATPase and Mg2+-ATPase activities, increases mitochondrial membrane potential, and decreases intracellular reactive oxygen species levels. Bacoside A specifically binds to calcium/calmodulin-dependent protein kinase IIA to trigger endoplasmic reticulum calcium release. Bacoside A exhibits non-apoptotic cytotoxicity against glioblastoma cells while protecting normal nerve cells from stress-induced damage. Bacoside A is applicable to the research of Parkinson's disease and glioblastoma multiforme.
For research use only. We do not sell to patients.
- CAS No.: 11028-00-5
- Formula: C41H68O13
- Molecular Weight:768.97
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Bacoside A
More
Biological Activity
Description
IC50 & Target
|
AChE |
CaMK IIα |
iNOS |
In Vitro
Bacoside A (8 μg/mL) induces non-apoptotic, macropinocytosis-driven cell death in LN229, U87MG and U251 glioblastoma cells, but exerts no cytotoxic effects on normal HaCaT or SVG cells[3].
Bacoside A (8 μg/mL) induces the formation of lysosome-precursor and caveolin-1-positive macropinosomes in LN229 and U87MG glioblastoma cells, thereby driving fluid accumulation and cell swelling[3].
Bacoside A (8 μg/mL; 24 h) specifically enhances the phosphorylation level of T286 in CaMK2A in LN229, U87MG and U251 glioblastoma cells, but exerts no effect on normal HaCaT or SVG cells[3].
Bacoside A (8 μg/mL; 24 h) induces CaMK2A phosphorylation in a calmodulin- and calcium-independent manner, whereas subsequent intracellular calcium release is required for macropinocytosis, cytoskeleton damage and cytotoxicity in LN229 and U87MG glioblastoma cells[3].
Bacoside A (0.2-1.0 mg/mL; 3 h) does not significantly reduce the viability of N2a neuroblastoma cells at concentrations up to 0.4 mg/mL, but decreases cell viability at higher concentrations; the cell viability remains above 100% at 0.6 mg/mL[4].
Bacoside A (0.4 mg/mL; 1 h) maintains nuclear integrity, reduces ROS production, and restores mitochondrial membrane potential in N2a neuroblastoma cells subjected to H2O2 (0.42 mM; 3 h) stress[4].
Bacoside A (0.4 mg/mL; 1 h) exhibits anti-apoptotic activity in N2a neuroblastoma cells stressed by H2O2 (0.42 mM; 3 h), but its effect is weaker than that of its monomeric components Bacoside A3 (HY-N5064), Bacopaside II (HY-N6016) and Bacopasaponin C (HY-N6015)[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:LN229, U87MG, U251 (human glioblastoma cell lines); HaCaT (normal human epidermal keratinocytes), SVG (normal human subventricular radial glial progenitors)
-
Concentration:2, 4, 6, 8 μg/mL (12 h); 8 μg/mL (12-24 h, 24-48 h, 24 h, 48 h)
-
Incubation Time:12 h (2, 4, 6, 8 μg/mL); 12-24 h, 24-48 h, 24 h, 48 h (8 μg/mL)
-
Result:Induced phase-lucent macropinosome-like vacuoles in LN229, U87MG, and U251 glioblastoma cells by 12-24 h at 8 μg/mL, which fused to occupy the entire cell space, causing cellular hypertrophy, swelling, rounding, and necrotic morphology by 24-48 h.
Caused near-complete cell death in treated glioblastoma cultures, while normal HaCaT and SVG cells showed no morphological changes or cytotoxicity at 8 μg/mL.
Resulted in negative TUNEL assay for apoptotic DNA fragmentation in treated LN229 and U87MG cells, confirming non-apoptotic cell death.
-
Cell Line:LN229, U87MG, U251 (human glioblastoma cell lines); HaCaT (normal human epidermal keratinocytes), SVG (normal human subventricular radial glial progenitors)
-
Concentration:8 μg/mL
-
Incubation Time:24 h
-
Result:Increased the ratio of phospho-CaMK2A (T286) to non-phospho CaMK2A significantly in LN229, U87MG, and U251 glioblastoma cells compared to untreated controls.
Caused no significant increase in phospho-CaMK2A levels in treated normal HaCaT or SVG cells.
-
Cell Line:H2O2-stressed N2a neuroblastoma cells
-
Concentration:0.4 mg/mL (post 3 h 0.42 mM H2O2 treatment)
-
Incubation Time:1 h (post 3 h 0.42 mM H2O2 treatment)
-
Result:Reduced Annexin V-FITC green fluorescence intensity in H2O2-stressed N2a cells, indicating decreased phosphatidylserine exposure.
Showed insignificant red fluorescence via PI staining, indicating minimal necrotic cell death.
Was less effective at alleviating apoptosis compared to individual bacoside A components bacoside A3, bacopaside II, and bacopasaponin C.
In Vivo
Bacoside A (5-20 mg/kg; i.p.; single administration 24 h prior to modeling) exerts a dose-dependent protective effect against Parkinson's disease-induced oxidative damage and neuronal degeneration in male Wistar rats. Among these doses, 20 mg/kg completely eliminates PD-induced changes in rotational behavior and restores multiple pathological markers to the levels observed in the sham-operated group[2].
Bacoside A exhibits chemopreventive efficacy against N-Nitrosodiethylamine (HY-N7434)-induced hepatocellular carcinoma in rats[3].
Bacoside A exerts anti-tumorigenic effects in mouse models of breast cancer, prostate cancer, and lung cancer[3].
Bacoside A has a good safety profile and does not impair the learning and memory abilities of mouse models with learning and memory impairment[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:albino Wistar (adult male, 150-200 g, morphine-induced oxidative stress model)[1]
-
Dosage:10 mg/kg b.w./day
-
Administration:p.o.; daily; 21 days
-
Result:Restored superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities to near normal, with significant increases relative to morphine-only treated rats.
Normalized reduced glutathione (GSH) levels relative to morphine-only treated rats.
Significantly decreased basal, FeSO4-induced, ascorbate-induced, and H2O2-induced lipid peroxide levels relative to morphine-only treated rats.
Reduced protein carbonyl content to 2.09 n mole/mg protein, a significant decrease relative to morphine-only treated rats.
Restored Na+/K+-ATPase activity to 0.54±0.03 mmol of phosphorous liberated/min/mg protein, Ca2+-ATPase activity to 0.53 mmol of phosphorous liberated/min/mg protein, and Mg2+-ATPase activity to 0.64 mmol of phosphorous liberated/min/mg protein, all significant increases relative to morphine-only treated rats.
Caused no significant changes in antioxidant enzyme activities, GSH levels, lipid peroxide levels, protein carbonyl content, or membrane-bound ATPase activities relative to control rats when administered alone.
-
Animal Model:Wistar rats (male, 8-10 weeks old, 295-340 g; Parkinson's disease model induced by 6-hydroxydopamine injection)[2]
-
Dosage:5 mg/kg; 10 mg/kg; 20 mg/kg
-
Administration:i.p.; single dose 24 hours pre-PD induction
-
Result:Reduced PD-induced elevated turning values in a dose-dependent manner; the 20 mg/kg dose completely eliminated the PD-induced increase in turning values.
Reversed PD-mediated suppression of serum CAT and GSH-Px activities in a dose-dependent manner; the 20 mg/kg dose effectively restored these enzyme activities to near sham levels.
Dose-dependently suppressed PD-induced elevated hippocampal AChE and iNOS activities; the 20 mg/kg dose reduced these activities to levels close to the sham group.
Dose-dependently reduced PD-induced elevated serum levels of IL-1β, IL-6, TNF-α, and NF-κB p65; the 20 mg/kg dose effectively reversed PD-mediated elevations of IL-1β and IL-6.
Dose-dependently reduced PD-induced elevated hippocampal levels of COX-2, p53, Bax, caspase-3, caspase-9, and cytochrome c; the 20 mg/kg dose reduced COX-2, p53, and cytochrome c levels to near sham group values.
Chemical Information
-
CAS No. 11028-00-5
-
Molecular Weight 768.97
-
Formula C41H68O13
-
SMILES
C/C(C)=C\CC[C@@]([C@@H]1[C@H]2CC[C@H]3[C@](CC[C@@H]4[C@]3(CO)CCC(O[C@H]5[C@H](O)[C@@H](O)[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O)CO6)[C@@H](CO)O5)C4(C)C)(C)[C@]2(C)CC1=O)(O)C
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Naunyn Schmiedebergs Arch Pharmacol
Integrating GEO, network pharmacology, and in vitro assays to explore the pharmacological mechanism of Bruceae Fructus against laryngeal cancer. [Abstract]2024 Jun;397(6):4165-4181. PMID: 38032489
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Ca2+ Staining Technique
Ca2+ staining is an experimental technique that utilizes specific fluorescent probes (such as Fluo-4 AM, Fura-2, etc.) to qualitatively or quantitatively detect dynamic changes in intracellular Ca2+ concentrations; this is achieved by monitoring the changes in fluorescent signals generated when these probes bind to free intracellular calcium ions. The underlying principle relies primarily on the presence of chelating groups within the probe's molecular structure that possess high affinity for calcium ions.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Human pluripotent stem cell midbrain dopaminergic neuron differentiation
Human pluripotent stem cells are directed toward midbrain dopaminergic neurons by first inducing a neural floor-plate-like progenitor state, then patterning cells with ventralizing SHH signaling and midbrain/WNT-FGF cues, and finally maturing progenitors into neurons expressing dopaminergic markers such as TH, NURR1/NR4A2, PITX3, DAT/SLC6A3, VMAT2/SLC18A2, GIRK2/KCNJ6, FOXA2, LMX1A, and EN1. The main readouts are loss of pluripotency, acquisition of FOXA2+/LMX1A+ midbrain floor-plate progenitors, emergence of βIII-tubulin+/MAP2+ neurons, and production of TH+ dopaminergic neurons with molecular, dopamine-release, and electrophysiological features of midbrain dopaminergic identity.
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Calcium Spark Assay
Calcium sparks are localized, transient increases in intracellular calcium concentration ([Ca2+]i) that occur in cardiac myocytes and represent elementary events underlying excitation-contraction coupling. These events are generated by the coordinated opening of clusters of ryanodine receptors (RyRs) on the sarcoplasmic reticulum membrane, leading to a brief release of Ca2+ into the cytosol. The detection and analysis of calcium sparks provide insights into the mechanisms of calcium handling and signaling in cardiac cells. Imaging techniques using fluorescent calcium indicators such as Fluo-3 are employed to visualize these subcellular calcium transients with high spatial and temporal resolution. The protocol is based on established methodologies described in primary literature for both experimental measurement and automated analysis of calcium sparks.
Purity & Documentation
-
Data Sheet (288 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Sumathi T, et al. Protective Effect of Bacoside-A against Morphine-Induced Oxidative Stress in Rats. Indian J Pharm Sci. 2011;73(4):409-415. [Content Brief]
[3]. John S, et al. Bacoside A Induces Tumor Cell Death in Human Glioblastoma Cell Lines through Catastrophic Macropinocytosis. Front Mol Neurosci. 2017;10:171. Published 2017 Jun 15. [Content Brief]
[4]. Bhardwaj P, et al. Comparative evaluation of four triterpenoid glycoside saponins of bacoside A in alleviating sub-cellular oxidative stress of N2a neuroblastoma cells. J Pharm Pharmacol. 2018;70(11):1531-1540. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)